SG Americas Securities’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.4M | Buy |
559,129
+487,734
| +683% | +$13.5M | 0.06% | 210 |
|
|
2025
Q1 | $2.02M | Sell |
71,395
-38,366
| -35% | -$1.09M | 0.01% | 713 |
|
|
2024
Q4 | $4.56M | Buy |
109,761
+56,982
| +108% | +$2.37M | 0.02% | 326 |
|
|
2024
Q3 | $3.53M | Sell |
52,779
-59,706
| -53% | -$3.99M | 0.01% | 455 |
|
|
2024
Q2 | $13.4M | Buy |
112,485
+33,175
| +42% | +$3.94M | 0.08% | 239 |
|
|
2024
Q1 | $8.45M | Buy |
79,310
+38,809
| +96% | +$4.14M | 0.04% | 380 |
|
|
2023
Q4 | $4.03M | Sell |
40,501
-172,166
| -81% | -$17.1M | 0.04% | 351 |
|
|
2023
Q3 | $22M | Buy |
212,667
+138,857
| +188% | +$14.3M | 0.25% | 47 |
|
|
2023
Q2 | $8.97M | Buy |
73,810
+49,335
| +202% | +$5.99M | 0.07% | 171 |
|
|
2023
Q1 | $3.76M | Sell |
24,475
-28,430
| -54% | -$4.37M | 0.04% | 326 |
|
|
2022
Q4 | $9.5M | Buy |
52,905
+36,526
| +223% | +$6.56M | 0.12% | 118 |
|
|
2022
Q3 | $1.94M | Sell |
16,379
-13,251
| -45% | -$1.57M | 0.02% | 487 |
|
|
2022
Q2 | $4.23M | Sell |
29,630
-170,320
| -85% | -$24.3M | 0.05% | 294 |
|
|
2022
Q1 | $34.4M | Buy |
199,950
+160,555
| +408% | +$27.7M | 0.25% | 46 |
|
|
2021
Q4 | $10M | Buy |
39,395
+16,063
| +69% | +$4.08M | 0.05% | 222 |
|
|
2021
Q3 | $8.98M | Buy |
23,332
+2,951
| +14% | +$1.14M | 0.04% | 258 |
|
|
2021
Q2 | $4.79M | Sell |
20,381
-125,249
| -86% | -$29.4M | 0.02% | 555 |
|
|
2021
Q1 | $19.1M | Buy |
145,630
+121,046
| +492% | +$15.9M | 0.1% | 153 |
|
|
2020
Q4 | $2.57M | Sell |
24,584
-65,047
| -73% | -$6.79M | 0.01% | 806 |
|
|
2020
Q3 | $6.34M | Buy |
89,631
+81,133
| +955% | +$5.74M | 0.04% | 207 |
|
|
2020
Q2 | $546K | Buy |
+8,498
| New | +$546K | ﹤0.01% | 1722 |
|